Form 4 for ORMP ORAMED PHARMACEUTICALS INC.
Accepted 2021-12-30 00:00:00 ET · period of report 2021-12-28 · accession 0001213900-21-068231 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2021-12-30 | 2021-12-28 | ORMP | KIDRON NADAV | Pres, CEO, Dir | F - Tax | $12.98 | -31.7K | 786.5K | -4% | -$411.8K | |
| 2021-12-30 | 2021-12-30 | ORMP | KIDRON NADAV | Pres, CEO, Dir | G - Gift | — | -20.0K | 766.5K | -3% | — |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2021-12-28 | F | D | 31,728 | $12.98 | 786,481 | D | — | — | |
| 2 | Common | Common Stock | 2021-12-30 | G | D | 20,000 | — | 766,481 | D | — | — | (F2) This transaction represents a charitable donation effective December 30, 2021. This is not a market transaction, thus no price has been reported. No value was received for the donated shares. The Reporting Person is not affiliated with, and has no control over, the donee. |